A 28-Day, Randomized, Controlled, Single-Blind, Phase 2 Study in Treatment-Resistant Major Depressive Disorder (TRD) Patients Receiving Intranasal Esketamine Comparing Addition of Almond Therapy TM with Treatment-as-Usual (TAU)

Authors
Category Primary study
JournalEUROPEAN PSYCHIATRY
Year 2023
This article has no abstract
Epistemonikos ID: 1ee14c2fbeddc25503984510cf152330b114374d
First added on: Dec 07, 2023